Skip to main content

Peer Review reports

From: Nivolumab plus ipilimumab versus nivolumab in individuals with treatment-naive programmed death-ligand 1 positive metastatic soft tissue sarcomas: a multicentre retrospective study

Original Submission
30 Aug 2020 Submitted Original manuscript
13 Oct 2020 Reviewed Reviewer Report
25 Oct 2020 Reviewed Reviewer Report
8 Dec 2020 Author responded Author comments - Yaolin Chen
Resubmission - Version 2
8 Dec 2020 Submitted Manuscript version 2
22 Dec 2020 Reviewed Reviewer Report
3 Jan 2021 Reviewed Reviewer Report
11 Jan 2021 Author responded Author comments - Yaolin Chen
Resubmission - Version 3
11 Jan 2021 Submitted Manuscript version 3
18 Jan 2021 Reviewed Reviewer Report
22 Jan 2021 Reviewed Reviewer Report
25 Jan 2021 Author responded Author comments - Yaolin Chen
Resubmission - Version 4
25 Jan 2021 Submitted Manuscript version 4
Publishing
26 Jan 2021 Editorially accepted
2 Feb 2021 Article published 10.1186/s12885-021-07843-3

You can find further information about peer review here.

Back to article page